vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与UNIFI INC（UFI）财务数据对比。点击上方公司名可切换其他公司
UNIFI INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$121.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -12.6%），UNIFI INC自由现金流更多（$24.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -9.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
优尼飞航空是北美规模最大的航空地勤服务供应商。公司成立于2018年末，达美航空将旗下子公司DAL环球服务的部分股权出售给阿根布莱特控股后，双方合资组建了该企业，目前阿根布莱特持有公司51%股份，达美航空持有49%股份。
PBYI vs UFI — 直观对比
营收规模更大
UFI
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出40.3%
-12.6%
自由现金流更多
UFI
多$9.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
-9.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $121.4M |
| 净利润 | — | $-9.7M |
| 毛利率 | 69.3% | 3.0% |
| 营业利润率 | 22.7% | -6.0% |
| 净利率 | — | -8.0% |
| 营收同比 | 27.7% | -12.6% |
| 净利润同比 | — | 14.8% |
| 每股收益（稀释后） | $0.26 | $-0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIUFI
| Q4 25 | $75.5M | $121.4M | ||
| Q3 25 | $54.5M | $135.7M | ||
| Q2 25 | $52.4M | $138.5M | ||
| Q1 25 | $46.0M | $146.6M | ||
| Q4 24 | $59.1M | $138.9M | ||
| Q3 24 | $80.5M | $147.4M | ||
| Q2 24 | $47.1M | $157.5M | ||
| Q1 24 | $43.8M | $149.0M |
净利润PBYIUFI
| Q4 25 | — | $-9.7M | ||
| Q3 25 | $8.8M | $-11.4M | ||
| Q2 25 | $5.9M | $15.5M | ||
| Q1 25 | $3.0M | $-16.8M | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | $20.3M | $-7.6M | ||
| Q2 24 | $-4.5M | $-4.0M | ||
| Q1 24 | $-4.8M | $-10.3M |
毛利率PBYIUFI
| Q4 25 | 69.3% | 3.0% | ||
| Q3 25 | 77.7% | 2.5% | ||
| Q2 25 | 76.5% | -0.8% | ||
| Q1 25 | 77.1% | -0.3% | ||
| Q4 24 | 76.4% | 0.4% | ||
| Q3 24 | 63.9% | 6.4% | ||
| Q2 24 | 77.4% | 6.9% | ||
| Q1 24 | 75.5% | 3.2% |
营业利润率PBYIUFI
| Q4 25 | 22.7% | -6.0% | ||
| Q3 25 | 17.6% | -7.1% | ||
| Q2 25 | 12.7% | 10.9% | ||
| Q1 25 | 8.7% | -9.5% | ||
| Q4 24 | 22.6% | -5.4% | ||
| Q3 24 | 27.4% | -2.2% | ||
| Q2 24 | -4.6% | -0.5% | ||
| Q1 24 | -5.3% | -4.6% |
净利率PBYIUFI
| Q4 25 | — | -8.0% | ||
| Q3 25 | 16.2% | -8.4% | ||
| Q2 25 | 11.2% | 11.2% | ||
| Q1 25 | 6.5% | -11.5% | ||
| Q4 24 | — | -8.2% | ||
| Q3 24 | 25.2% | -5.2% | ||
| Q2 24 | -9.6% | -2.5% | ||
| Q1 24 | -11.0% | -6.9% |
每股收益（稀释后）PBYIUFI
| Q4 25 | $0.26 | $-0.53 | ||
| Q3 25 | $0.17 | $-0.62 | ||
| Q2 25 | $0.12 | $0.85 | ||
| Q1 25 | $0.06 | $-0.92 | ||
| Q4 24 | $0.40 | $-0.62 | ||
| Q3 24 | $0.41 | $-0.42 | ||
| Q2 24 | $-0.09 | $-0.21 | ||
| Q1 24 | $-0.10 | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $30.2M |
| 总债务越低越好 | $22.7M | $92.6M |
| 股东权益账面价值 | $130.3M | $230.0M |
| 总资产 | $216.3M | $382.9M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.40× |
8季度趋势，按日历期对齐
现金及短期投资PBYIUFI
| Q4 25 | $97.5M | $30.2M | ||
| Q3 25 | $94.4M | $20.6M | ||
| Q2 25 | $96.0M | $22.7M | ||
| Q1 25 | $93.2M | $16.3M | ||
| Q4 24 | $101.0M | $18.7M | ||
| Q3 24 | $96.7M | $13.7M | ||
| Q2 24 | $96.8M | $26.8M | ||
| Q1 24 | $107.2M | $27.7M |
总债务PBYIUFI
| Q4 25 | $22.7M | $92.6M | ||
| Q3 25 | $34.0M | $107.5M | ||
| Q2 25 | $45.3M | $95.7M | ||
| Q1 25 | $56.7M | $127.9M | ||
| Q4 24 | $68.0M | $123.0M | ||
| Q3 24 | $79.3M | $119.3M | ||
| Q2 24 | $90.7M | $117.8M | ||
| Q1 24 | $102.0M | $116.1M |
股东权益PBYIUFI
| Q4 25 | $130.3M | $230.0M | ||
| Q3 25 | $115.3M | $241.1M | ||
| Q2 25 | $104.7M | $249.5M | ||
| Q1 25 | $97.1M | $228.4M | ||
| Q4 24 | $92.1M | $237.2M | ||
| Q3 24 | $71.1M | $259.7M | ||
| Q2 24 | $48.5M | $263.4M | ||
| Q1 24 | $51.0M | $277.8M |
总资产PBYIUFI
| Q4 25 | $216.3M | $382.9M | ||
| Q3 25 | $202.9M | $424.6M | ||
| Q2 25 | $194.9M | $426.9M | ||
| Q1 25 | $196.2M | $446.5M | ||
| Q4 24 | $213.3M | $439.7M | ||
| Q3 24 | $220.7M | $467.0M | ||
| Q2 24 | $205.0M | $469.2M | ||
| Q1 24 | $214.1M | $482.6M |
负债/权益比PBYIUFI
| Q4 25 | 0.17× | 0.40× | ||
| Q3 25 | 0.30× | 0.45× | ||
| Q2 25 | 0.43× | 0.38× | ||
| Q1 25 | 0.58× | 0.56× | ||
| Q4 24 | 0.74× | 0.52× | ||
| Q3 24 | 1.12× | 0.46× | ||
| Q2 24 | 1.87× | 0.45× | ||
| Q1 24 | 2.00× | 0.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $25.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $24.2M |
| 自由现金流率自由现金流/营收 | 19.1% | 20.0% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $1.4M |
8季度趋势，按日历期对齐
经营现金流PBYIUFI
| Q4 25 | $14.4M | $25.3M | ||
| Q3 25 | $9.7M | $-8.9M | ||
| Q2 25 | $14.1M | $-1.3M | ||
| Q1 25 | $3.6M | $-5.0M | ||
| Q4 24 | $15.6M | $-2.2M | ||
| Q3 24 | $11.0M | $-12.8M | ||
| Q2 24 | $1.0M | $932.0K | ||
| Q1 24 | $11.2M | $-1.4M |
自由现金流PBYIUFI
| Q4 25 | $14.4M | $24.2M | ||
| Q3 25 | $9.7M | $-10.9M | ||
| Q2 25 | $14.1M | $-3.9M | ||
| Q1 25 | $3.6M | $-8.0M | ||
| Q4 24 | $15.6M | $-5.1M | ||
| Q3 24 | $11.0M | $-14.9M | ||
| Q2 24 | $1.0M | $-1.7M | ||
| Q1 24 | — | $-3.9M |
自由现金流率PBYIUFI
| Q4 25 | 19.1% | 20.0% | ||
| Q3 25 | 17.7% | -8.1% | ||
| Q2 25 | 26.8% | -2.8% | ||
| Q1 25 | 7.7% | -5.4% | ||
| Q4 24 | 26.4% | -3.7% | ||
| Q3 24 | 13.7% | -10.1% | ||
| Q2 24 | 2.1% | -1.1% | ||
| Q1 24 | — | -2.6% |
资本支出强度PBYIUFI
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.0% | 1.9% | ||
| Q1 25 | 0.1% | 2.0% | ||
| Q4 24 | 0.0% | 2.1% | ||
| Q3 24 | 0.0% | 1.4% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率PBYIUFI
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | -0.09× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
UFI
| Other | $67.8M | 56% |
| REPREVE Fiber | $34.3M | 28% |
| Export Sales From US Operations | $10.5M | 9% |
| All Other Foreign Countries | $8.8M | 7% |
